HCV infection and extrahepatic manifestations

Hepato-Gastroenterology

Volumn 50, Issue 52, 2003, Pages 1149-1154

  Nocente, Roberto ^a,b   Ceccanti, Mauro ^a   Bertazzoni, Giuliano ^a   Cammarota, Giovanni ^b   Silveri, Nicolò Gentiloni ^b   Gasbarrini, Giovanni ^b  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b NONE

Author keywords

Essential mixed cryoglobulinemia; Extrahepatic manifestations; HCV

Indexed keywords

ALPHA INTERFERON; ANTINUCLEAR ANTIBODY; CRYOGLOBULIN; SMOOTH MUSCLE ANTIBODY;

ANTIPHOSPHOLIPID SYNDROME; CLINICAL FEATURE; CRYOGLOBULINEMIA; DIABETES MELLITUS; DISEASE ASSOCIATION; FIBROSING ALVEOLITIS; HASHIMOTO DISEASE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HYPERTHYROIDISM; IDIOPATHIC THROMBOCYTOPENIC PURPURA; LACRIMAL GLAND DISEASE; LICHEN PLANUS; NEUROPATHY; PATHOGENESIS; POLYARTERITIS NODOSA; PORPHYRIA CUTANEA TARDA; PRIORITY JOURNAL; REVIEW; RHEUMATOID ARTHRITIS; SIALOADENITIS; SJOEGREN SYNDROME; THYROID DISEASE; VASCULITIS; VIREMIA;

ANTIPHOSPHOLIPID SYNDROME; CRYOGLOBULINEMIA; HEPATITIS C; HUMANS; LUNG DISEASES, INTERSTITIAL; LYMPHOPROLIFERATIVE DISORDERS; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC; SKIN DISEASES; THYROID DISEASES;

EID: 0038677080     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (47)

1. Hadziyannis SJ: The spectrum of extrahepatic manifestations in hepatitis C virus infection. J Vir Hepat 1997; 4:9-28.
2. Ferri C, La Civita L, Longobardo G, Zignego AL, Pasero G: Mixed cryoglobulinemia: a cross-road between autoimmune and lymphoproliferative disorders. Lupus 1998; 7(4):275-279.
3. Mc Murray R W: Hepatitis C associated autoimmune disorders. Rheum Dis Clin North Aro 1998; 24(2):353-374.
4. Calligaris Cappio F, De Leo AM, Bertero MT: Autoimmune phenomena and hepatitis C virus in lymphoproliferative and connective tissue disorders. Leuk Lymphoma 1997; 28(1-2):57-63.
5. Suhash C. Gumber MD, and Sanjiv Chopra MD: Hepatitis C, a multifaced disease. Ann Intern Med 1995; 123:615-620.
6. Zaltron S, Puoti M, Liberini P, Antonini L, Quinzanini M, Manni M, Forleo MA, Rossi S: Spinetti A, Zanini B, Carosi G: High prevalence of peripheral neuropathy in hepatitis C virus infected patients with symptomatic and asymptomatic cryoglobulinaemia. Ital J Gastroenterol Hepatol 1998; 30:391-395.
7. Ferri C, La Civita L, Fazzi P, Solfanelli S, Lombardini F, Begliomini E, Monti M, Longombardo G, Pasero G, Zignego L: Interstitial lung fibrosis and rheumatic disorders in patients with Hepatitis C virus infection. Br J Rheum 1997; 36:360-365.
8. Ferri C, Monti M, La Civita L, et al: Hepatitis C virus infection in non-Hodgkin's B-cell Lymphoma complicating mixed cryoglobulinaemia. Eur J Invest 1994; 24:781-784.
9. Zignego AL, Ferri C, Giannini C, et al: HCV infection in B-cell non-Hodgkin's lymphoma. J Hepatol 1995; 23(Suppl 1):77. (Abstract)
10. Silvestri F, Pipan C, Barillari G, Zaja F, Fanin R, Infanti L, Russo D, Falasca E, Botta Ga Baccarini M: Prevalence of hepatitis C virus infection in patients with lymphoproliferative disorders. Blood 1996; 10:4296-4301.
11. Casal MR, Trejo O, Carrasco MG, Cerera R, Font J: Mixed cryoglobulinemia: new concepts. Lupus 2000; 9:83-91.
12. Nagamine T, Ohtuka T, Takehara K, Arai T, Takagi H, Mori M: Thrombocytopenia associated with hepatitis C viral infection J Hepatol 1996; 24:135-140.
13. Hadziyannis SJ: Nonhepatic manifestation and combined diseases in HCV infection. Dig Dis Sci 1996; 41:63S-74S.
14. Pawlotsky JM Bouvier M, Fromont P, et al: Hepatitis C virus infection and autoimmune throbocytopenic purpura. J Hepatol 1995; 23:635-639.
15. Prieto J, Yuste JR, Beloqui O, et al: Anticardiolipin antibodies in chronic hepatitis C: implication of hepatitis C virus as the cause of the antiphospholipid syndrome. Hepatology 1996; 23:199-204.
16. Al-Saeed A, Makris M, Malia RG, et al: The development of antiphospholipid antibodies in haemophilia is linked to infection with hepatitis C. Br J Haematol 1994; 88:845-848.
17. Dalekos GN, Kistis KG, Boumba DS, et al: Increased incidence of anticardiolipin antibodies in patient with Hepatitis C is not associated with aethiopathogenetic link to anti-phospholipid syndrome. Eur J Gastroenterol Hepatol 2000; 12:67-74.
18. McNeil HP, Simpson RJ, Chestrman CN, Krilis SA: Antiphospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: beta-2-glycoprotein-1(apolipoprotein H). Proc Natl Acad Sci USA 1990; 87:4120-4124.
19. Harris EN, Gharavi AE, Hedge U, et al: Anticardiolipin antibodies in autoimmune Thrombocytopenic purpura. Br J Haematol 1985; 59:231-234.
20. Quaranta J R, Tran A, Regnier D, et al: High prevalence of antibodies to hepatitis C virus (HCV) in patients with anti-thiroid autoantibodies. J Hepatol 1993; 18:136-138.
21. Serejo F, Gloria H, Marinho R, Raimundo M, Ramalho F, Carneiro De Mura M: Autoimmunity and thyroid dysfunction in chronic hepatitis treated with interferon. Hepatology 1995; 22(N 4 Pt.2): 351a. (Abstract)
22. Haddad J, Deny P, Munz-Gotheil C, et al: Lymphocytic sialadenitis of Sjogren's syndrome associated with chronic hepatitis C virus liver disease. Lancet 1992; 339:321-323.
23. Daruich JR, Zas M, Findor JA, Santarelli MT, Demetrio C, Bar J: Lacrimar disfunction in patients with chronic HCV infection. Hepatology 1995; 22(N 4 P.t2): 406A. (Abstract)
24. Pemey P, Jorgensen C, Legouffe MC, et al: Prospective study of primary Sjogren syndrome associated to HCV-infected patients: Clinical immunological, genetical and viral genotype characteristics. Hepatology 1995; 22(N 4 Pt.2):352A. (Abstract)
25. Di Cesare E, Previti M, Russo F, et al: Interferon κ therapy may induce insulin autoantibody development in patients with chronic viral hepatitis. Dig Dis Sci 1996; 41:1672-1677.
26. Fargion S, Piperno A, Cappellini MD, et al: Hepatitis C virus and porphyria cutanea tarda: Evidence of a strong association. Hepatology 1992; 16:1322-1326.
27. De Castro M, Sanchez J, Herrera JF, et al: Hepatitis C virus antibodies and liver disease in patient with porphyria cutanea tarda: Hepatology 1993; 17:551-557.
28. Daoud MS, Gibson LE, Daoud S, El Azhary RA: Chronic hepatitis C and skin diseases: a review. Mayo Clin Proc 1995; 1995:559-564.
29. Navas S, Bosch O, Castillo I, Marriot E, Carreno V: Porphyria cutanea tarda and hepatitis C and viruses B infection: A retrospective study. Inter Hepatol Commun 1995; 21:279-284.
30. Sampietro M, Fracanzani AL, Corbetta N, et al: HCV type 1b in patient with chronic liver disease and porphyria cutanea tarda (PCT2). Hepatology 1995; 22(N 4 Pt.2):350A. (Abstract)
31. Pawlotsky JM, Dhumeaux D, Bagot M: Hepatitis C in dermatology. Arch Dermatol 1995; 131:1185-1193.
32. Agnello V, Abel G: Localization of hepatitis C virus in cutaneous vasculitic lesions in patients with type II cryoglobulinemia. Arthritis Rheum 1997; 40:2007-2015.
33. Pyrsopoulos NT, Reddy K: Extrahepatic manifestations of chronic viral hepatitis. Curr. Gastroenterol Rep 2001; 3(1):71-78.
34. Cedrone A, Covino M, Caturelli E, Pompili M, Lorenzelli G, Villani MR, Valle D, Sperandeo M, Rapaccini GL, Gasbarrini G: Utility of alpha-fetoprotein (AFP) in the screening of patients with virus-related chronic liver disease: does different viral etiology influence AFP levels in HCC? A study in 350 western patients. Hepatogastroenterology 2000; 47(36):1654-1658.
35. Mukaiya M, Nishi M, Miyake H, Hirata K: Chronic liver diseases for the risk of hepatocellular carcinoma: a case-control study in Japan. Etiologic association of alcohol consumption, cigarette smoking and the development of chronic liver diseases. Hepatogastroenterology 1998; 45(24):2328-2332.
36. Unoura M, Kaneko S, Matsushita E, Shimoda A, Takeuchi M, Adachi H, Kawai H, Urabe T, Yanagi M, Matsui O, et al: High-risk groups and screening strategies for early detection of hepatocellular carcinoma in patients with chronic liver disease. Hepatogastroenterology 1993; 40(4):305-310.
37. Tran A, Longo F, Ouzan S, et al: Effects of 1-year Interferon-κ 2a treatment in patient with chronic hepatitis C and persistently normal transaminase activity. Scan J Gastroenterol 2000; 4:433-437.
38. Hoofnagle JH, Di Bisceglie AM: The treatment of chronic viral hepatitis. N Engl J Med 1997; 336:347-354.
39. Lunel F, Cacoub P: Treatment of autoimmune and extra-hepatic manifestations of hepatitis C virus infection. J Hepatol 1999; 31(Suppl 1):210-216. (Review)
40. Okano J, Horie Y, Kawasaki H, Kondo M: Interferon treatment of porphyria cutanea tarda associated with chronic hepatitis type C. Hepatogastroenterology 1997; 44(14):525-528.
41. Bayraktar Y, Bayraktar M, Gurakar A, Hassanein TI, Van Thiel DH: A comparison of the prevalence of autoantibodies in individuals with chronic hepatitis C and those with autoimmune hepatitis: the role of interferon in the development of autoimmune diseases. Hepatogastroenterology 1997; 44(14):417-425.
42. Manns MP, Rambusch EG: Autoimmunity and extrahepatic manifestations in hepatitis C virus infection. J Hepatol 1999; 31(Suppl 1):39-42.
43. Cammarota G, Cuoco L, Cianci R, Pandolfi F, Gasbarrini G: Onset of coeliac disease during treatment with interferon for chronic hepatitis C. Lancet 2000; 356 (9240):1494-1495.
44. Lunel F, Cacoub P: Treatment of autoimmune and extra-hepatic manifestations of hepatitis C virus infection. J Hepatol 1999; 31(Suppl 1:210-216.
45. Landau A, Batisse D, Van Huyen JPD: Efficacy and safety of combination therapy with interferon α2b and ribavirin for chronic hepatitis C in HIV-infected patients. AIDS 2000; 14:839-844.
46. Hasan F, Asker H, al Shamali M, al Kalaoui M, al Nakib B: Interferon-alpha plus ribavirin combination therapy for the treatment of chronic hepatitis C in interferon non-responders. Hepatogastroenterology 2000; 47(36):1642-1644.
47. Brillanti S, Levantesi F, Masi L, Foli M, Bolondi L: Triple antiviral Therapy as a new option for patients with interferon non responsive chronic hepatitis C. Hepatology 2000; 32:630-634.